Healthcare -
Biotechnology - NASDAQ - US
$ 6.81
-1.59 %
$ 1.01 B
Market Cap
-5.08
P/E
Price Target
Average
50.51%
Revenue Forecast
Estimate
55.76%
EBIT
Estimate
--14.99%
Net Income
Estimate
54.59%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Adaptive Biotechnologies Corporation
Wall Street analysts predict an average 1-year price target for ADPT of $10.2 , with forecasts ranging from
a
low of
$5 to a high of $18 .
ADPT Lowest Price Target
Wall Street Target
5 USD
-26.58%
ADPT Average Price Target
Wall Street Target
10.2 USD
50.51%
ADPT Highest Price Target
Wall Street Target
18 USD
164.32%
REVENUE FORECAST
Revenue Forecast Chart ADPT
EBIT FORECAST
EBIT Forecast Chart ADPT
NET INCOME FORECAST
Net Income Chart ADPT